Amgen is launching a Phase 1/2 clinical trial to evaluate its investigational AMG 592 therapy in treating active systemic lupus…
Articles by Alice Melão
Researchers at the University of Houston have been awarded a $600,000 grant by the Lupus Research Alliance to design new approaches for targeting…
Researchers have found that the antibody epratuzumab, which targets CD22 receptors, significantly reduces the activity of systemic lupus erythematosus (SLE)…
Treatment with H.P. Acthar Gel (repository corticotropin injection) can effectively help manage systemic lupus erythematosus (SLE) symptoms in…
A new approach to treating lupus, based on attacking a wide array of disease-implicated molecular pathways, showed promise in a new study…
Patients with systemic lupus erythematosus (SLE) have higher incidence of subclinical atherosclerosis markers compared to heathy people, a French study…
Approximately one-third of patients with systemic lupus erythematosus (SLE) admit to self-managing their corticosteroid medication without the consent of their…
With a $387,000 grant from the National Institutes of Health, researchers at the University of Houston are developing a new diagnostic test…
EMD Serono‘s atacicept can effectively reduce disease activity among lupus patients with high disease activity at baseline, according to…
Cardiac tamponade, the accumulation of fluid around the heart, affects nearly 6 percent of lupus patients in India, a…